I recommend a speculative buy on Factorial Energy Inc. due to attractive risk/reward at near-SPAC valuation despite high risk. FAC has achieved significant OEM validation, delivering high-density ...

Factorial Energy (NASDAQ:FAC) is focusing on execution, customer validation and a capital-light manufacturing strategy following its recent Nasdaq listing, CEO and co-founder Dr. Siyu Huang said ...

THE publications of the various Imperial Bureaux are necessarily of very unequal scientific value, and naturally also, appeal to very different bodies of scientific workers. Their format and ...

Recursion Pharmaceuticals (RXRX) ended the recent trading session at $3.34, demonstrating a +1.21% change from the preceding day's closing price. The stock outpaced the S&P 500's daily gain of 0.38%.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...